期刊文献+

髓系来源抑制细胞在胃癌患者外周血和肿瘤组织中的数量及其临床意义 被引量:5

The number of myeloid-derived suppressor cells in the peripheral blood and tumor tissues in patients with gastric cancer and its clinical significance
下载PDF
导出
摘要 目的观察髓系来源抑制细胞(MDSC)在胃癌患者外周血的数量和肿瘤组织、癌旁组织的表达,探讨MDSC的数量与胃癌患者临床病理特征间的关系。方法收集62例胃癌患者外周血和其中12例患者的新鲜肿瘤组织和癌旁组织以及20份健康志愿者外周血,流式细胞仪分析HLA-DR-CD33+CD11b+MDSC的数量,采用One-way ANOVA和Mann-Whitney U检验以及t检验分析胃癌患者外周血MDSC的数量与肿瘤的浸润深度、分化程度、患者TNM分期和淋巴结转移的关系。结果和健康志愿者相比,初诊胃癌患者外周血MDSC数量增加(P<0.01);MDSC在胃癌患者外周血的数量与肿瘤的浸润深度、分化程度、患者TNM分期和淋巴结转移显著相关(P<0.05);MDSC在同一病人胃癌组织中的表达明显高于癌旁组织;复发/转移组患者外周血MDSC的数量明显高于无复发/转移患者(P<0.05);胃癌患者外周血HLA-DR-CD33+CD11b+MDSC高表达负性协同刺激分子T细胞免疫球蛋白黏蛋白分子3(Tim-3)。结论 MDSC在胃癌患者外周血的数量与肿瘤恶性程度及复发转移密切相关。 Objective To investigate the number of myeloid-derived suppressor cells (MDSCs) in peripheral blood, tumor tissue and para-tumor normal tissues in patients with gastric cancer in an attempt to explore the relationship between MDSCs expression and clinicopathologic characteristics. Methods Peripheral blood was collected from 62 gastric cancer patients and 20 healthy volunteers (HC group). Gastric cancer tissues and adjacent normal tissues were obtained from 12 of the 62 gastric cancer patients. HLA-DR-CD33 + CD11b+ MDSCs were analyzed by flow cytometry. Student's t-test, One-way ANOVA and Mann-Whitney U test were used to explore the correlation between MDSCs expression in peripheral blood and the depth of tumor invasion, degree of differentiation, TNM stage and lymph node metastasis. Results Compare with the HC group, the number of MDSCs in peripheral blood of newly-diagnosed gastric cancer patients was higher ( P 〈 0.01 ). The number of MDSCs in peripheral blood of gastric cancer patients was significantly associated with the depth of invasion, degree of differentiation, TNM stage and lymph node metastasis (P 〈0.05). The expression of MDSCs from gastric cancer tissues was obviously higher than that of the adjacent tissues in the same patient. The number of MDSCs in peripheral blood from recurrent/metastasis group was obviously higher than that from non-recurrent/metastasis group ( P 〈 0.05). In addition, compare with the HC group, the expression of negative costimulatory molecule T-cell immunoglobulin- and mucin-domain- containing molecule 3 (Tim-3) on HLA-DR-CD33+ CD11b + MDSCs in peripheral blood was higher in patients with gastric cancer. Conclusion MDSCs expression in peripheral blood of gastric cancer patients was closely associated with tumor malignant degree and tumor recurrence/metastasis.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2014年第7期740-743,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 江苏省自然科学基金(BK2011289) 苏州市社会发展项目(SYS201009)
关键词 髓系来源抑制细胞 胃癌 肿瘤免疫逃逸 T细胞免疫球蛋白黏蛋白分子3 myeloid-derived suppressor cell gastric cancer tumor immune escape T-cell immunoglobulin-and mucin-domain-containing molecule 3
  • 相关文献

参考文献1

二级参考文献25

  • 1Pardoll D. Does the immune system see tumors as foreign or self? Annu Rev Imrnuno12003; 21:807-839.
  • 2Rabinovich CA, Gabrilovich D, Sotomayor EM. Immuno- suppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007; 25:267-296.
  • 3Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009; 9:162-174.
  • 4Kusmartsev S, Gabrilovich DI. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunol Immunother 2006; 55:237-245.
  • 5Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007; 117:1155-1166.
  • 6Talmadge JE. Pathways mediating the expansion and im- munosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clin Cancer Res 2007; 13:5243-5248.
  • 7Almand B, Clark JI, Nikitina E, van Beynen J, English NR, Knight SC, Carbone DP, Gabrilovich DI. Increased produc- tion of immature myeloid cells in cancer patients: a mecha- nism of immunosuppression in cancer. J Immunol 2001; 166: 678-689.
  • 8Zea AH, Rodriguez PC, Atkins MB, Hernandez C, Signo- retti S, Zabaleta J, McDermott D, Quiceno D, Youmans A, O'Neill A, Mier J, Ochoa AC. Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mecha- nism of tumor evasion. Cancer Res 2005; 65:3044-3048.
  • 9Diaz-Montero CM, Salem ML, Nishimura MI, Garrett-May- er E, Cole DJ, Montero AJ. Increased circulating myeloid- derived suppressor ceils correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophospha- mide chemotherapy. Cancer Immunol Immunother 2009; 58: 49-59.
  • 10Gallina G, Dolcetti L, Serafini P, De Santo C, Marigo I, Co- lombo MP, Basso G, Brombacher F, Borrello I, Zanovello P, Bicciato S, Bronte V. Tumors induce a subset of inflamma- tory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest 2006; 116:2777-2790.

共引文献21

同被引文献20

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部